BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21536019)

  • 1. Detection of autoantibodies against Rabphilin-3A-like protein as a potential biomarker in patient's sera of colorectal cancer.
    Chen JS; Kuo YB; Chou YP; Chan CC; Fan CW; Chen KT; Huang YS; Chan EC
    Clin Chim Acta; 2011 Jul; 412(15-16):1417-22. PubMed ID: 21536019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of colorectal cancer.
    Fan CW; Kuo YB; Lin GP; Chen SM; Chang SH; Li BA; Chan EC
    Clin Chim Acta; 2017 Dec; 475():157-163. PubMed ID: 29074220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined analysis of survivin autoantibody and carcinoembryonic antigen biomarkers for improved detection of colorectal cancer.
    Chen JS; Chen KT; Fan WC; Yu JS; Chang YS; Chan EC
    Clin Chem Lab Med; 2010 May; 48(5):719-25. PubMed ID: 20178447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting.
    Chen H; Werner S; Butt J; Zörnig I; Knebel P; Michel A; Eichmüller SB; Jäger D; Waterboer T; Pawlita M; Brenner H
    Oncotarget; 2016 Mar; 7(13):16420-32. PubMed ID: 26909861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Blood Autoantibodies in the Detection of Colorectal Cancer.
    Negm OH; Hamed MR; Schoen RE; Whelan RL; Steele RJ; Scholefield J; Dilnot EM; Shantha Kumara HM; Robertson JF; Sewell HF
    PLoS One; 2016; 11(7):e0156971. PubMed ID: 27383396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel multiplex beads-based assay for autoantibody detection for colorectal cancer diagnosis.
    Villar-Vázquez R; Padilla G; Fernández-Aceñero MJ; Suárez A; Fuente E; Pastor C; Calero M; Barderas R; Casal JI
    Proteomics; 2016 Apr; 16(8):1280-90. PubMed ID: 26915739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of distinct serum proteomics for the biomarkers discovery in colorectal cancer.
    Xu W; Hu Y; Li J; He X; Fu Z; Pan T; Liu H; He H; Ge W; Yu J; Wei Q; Zheng S; Chen Y; Zhang S
    Discov Med; 2015 Oct; 20(110):239-53. PubMed ID: 26562477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of rabphillin-3A-like gene in colorectal cancers.
    Goi T; Takeuchi K; Katayama K; Hirose K; Yamaguchi A
    Oncol Rep; 2002; 9(6):1189-92. PubMed ID: 12375017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic potential of zinc finger protein-specific autoantibodies and associated linear B-cell epitopes in colorectal cancer.
    O'Reilly JA; Fitzgerald J; Fitzgerald S; Kenny D; Kay EW; O'Kennedy R; Kijanka GS
    PLoS One; 2015; 10(4):e0123469. PubMed ID: 25875936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple serological biomarkers for colorectal cancer detection.
    Chan CC; Fan CW; Kuo YB; Chen YH; Chang PY; Chen KT; Hung RP; Chan EC
    Int J Cancer; 2010 Apr; 126(7):1683-90. PubMed ID: 19795454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplexed VeraCode bead-based serological immunoassay for colorectal cancer.
    Ostendorff HP; Awad A; Braunschweiger KI; Liu Z; Wan Z; Rothschild KJ; Lim MJ
    J Immunol Methods; 2013 Dec; 400-401():58-69. PubMed ID: 24161315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis.
    Sun L; Hu S; Yu L; Guo C; Sun L; Yang Z; Qi J; Ran Y
    Int J Cancer; 2016 Jun; 138(11):2724-31. PubMed ID: 26756179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of autoantibody signatures as biomarkers for early detection of colorectal carcinoma.
    Chang W; Wu L; Cao F; Liu Y; Ma L; Wang M; Zhao D; Li P; Zhang Q; Tan X; Yu Y; Lou Z; Zhao J; Zhang H; Fu C; Cao G
    Clin Cancer Res; 2011 Sep; 17(17):5715-24. PubMed ID: 21771877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer.
    Fijneman RJ; de Wit M; Pourghiasian M; Piersma SR; Pham TV; Warmoes MO; Lavaei M; Piso C; Smit F; Delis-van Diemen PM; van Turenhout ST; Terhaar sive Droste JS; Mulder CJ; Blankenstein MA; Robanus-Maandag EC; Smits R; Fodde R; van Hinsbergh VW; Meijer GA; Jimenez CR
    Clin Cancer Res; 2012 May; 18(9):2613-24. PubMed ID: 22351690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma heat shock protein 90-alpha have an advantage in diagnosis of colorectal cancer at early stage.
    Kasanga M; Liu L; Xue L; Song X
    Biomark Med; 2018 Aug; 12(8):881-890. PubMed ID: 29939072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of anti-GRP78 antibodies in the serum of patients with colorectal carcinoma: a potential biomarker for early cancer detection.
    Raiter A; Vilkin A; Gingold R; Levi Z; Halpern M; Niv Y; Hardy B
    Int J Biol Markers; 2014 Dec; 29(4):e431-5. PubMed ID: 24803280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Implications of Rabphillin-3A-Like Gene Alterations in Breast Cancer.
    Putcha BD; Jia X; Katkoori VR; Salih C; Shanmugam C; Jadhav T; Bovell LC; Behring MP; Callens T; Messiaen L; Bae S; Grizzle WE; Singh KP; Manne U
    PLoS One; 2015; 10(6):e0129216. PubMed ID: 26070152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer.
    Chen H; Werner S; Tao S; Zörnig I; Brenner H
    Cancer Lett; 2014 May; 346(2):178-87. PubMed ID: 24462820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case-controlled identification of colorectal cancer based on proteomic profiles and the potential for screening.
    Huijbers A; Mesker WE; Mertens BJ; Bladergroen MR; Deelder AM; van der Burgt YE; Tollenaar RA
    Colorectal Dis; 2014 Nov; 16(11):907-13. PubMed ID: 25243779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological immune response against ADAM10 pro-domain is associated with favourable prognosis in stage III colorectal cancer patients.
    Álvarez-Fernández SM; Barbariga M; Cannizzaro L; Cannistraci CV; Hurley L; Zanardi A; Conti A; Sanvito F; Innocenzi A; Pecorelli N; Braga M; Alessio M
    Oncotarget; 2016 Nov; 7(48):80059-80076. PubMed ID: 27517630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.